Next Article in Journal
Steroid Nanocrystals Prepared Using the Nano Spray Dryer B-90
Next Article in Special Issue
Vaccine Safety Surveillance Systems: Critical Elements and Lessons Learned in the Development of the US Vaccine Safety Datalink’s Rapid Cycle Analysis Capabilities
Previous Article in Journal
Pharmacokinetic Evaluation of a DSPE-PEG2000 Micellar Formulation of Ridaforolimus in Rat
Previous Article in Special Issue
Signal Detection and Monitoring Based on Longitudinal Healthcare Data
Article Menu

Export Article

Open AccessArticle
Pharmaceutics 2013, 5(1), 94-106;

Safety Monitoring in Clinical Trials

Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA
Author to whom correspondence should be addressed.
Received: 6 November 2012 / Revised: 9 January 2013 / Accepted: 10 January 2013 / Published: 17 January 2013
(This article belongs to the Special Issue Drug Safety and Pharmacovigilance)
Full-Text   |   PDF [442 KB, uploaded 17 January 2013]   |  


Monitoring patient safety during clinical trials is a critical component throughout the drug development life-cycle. Pharmaceutical sponsors must work proactively and collaboratively with all stakeholders to ensure a systematic approach to safety monitoring. The regulatory landscape has evolved with increased requirements for risk management plans, risk evaluation and minimization strategies. As the industry transitions from passive to active safety surveillance activities, there will be greater demand for more comprehensive and innovative approaches that apply quantitative methods to accumulating data from all sources, ranging from the discovery and preclinical through clinical and post-approval stages. Statistical methods, especially those based on the Bayesian framework, are important tools to help provide objectivity and rigor to the safety monitoring process. View Full-Text
Keywords: clinical trial; safety monitoring; Data and Safety Monitoring Board (DSMB); sequential probability ratio test (SPRT); Bayesian methods clinical trial; safety monitoring; Data and Safety Monitoring Board (DSMB); sequential probability ratio test (SPRT); Bayesian methods

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Yao, B.; Zhu, L.; Jiang, Q.; Xia, H.A. Safety Monitoring in Clinical Trials. Pharmaceutics 2013, 5, 94-106.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top